Clinical Trials Browser

INDUSTRY × Brentuximab Vedotin × 90 days × Clear all

NCT04404283 2026-04-20

ECHELON-3

Phase 3 Active not recruiting

239 enrolled 1 FDA

Lymphoma, Large B-Cell, Diffuse

NCT05481437 2026-04-13

A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

Hodgkin Disease

NCT04609566 2026-03-16

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Phase 2 Completed

DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma